Biotin-conjugated hexapeptide-2 derivative and use thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9180082
APP PUB NO 20150057230A1
SERIAL NO

14388771

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to a biotin-conjugated hexapeptide-2 derivative or a pharmaceutically acceptable salt thereof and use thereof. More particularly, the present invention relates to a biotin-conjugated hexapeptide-2 derivative or a pharmaceutically acceptable salt thereof, a preparation method thereof, a composition including the same as an active ingredient, and a method for improving wrinkles and inhibiting skin aging using the same.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
INCOSPHARM CORPORATIONDAEJEON 305-806

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Kwon, Seon-Deok Daejeon, KR 3 2
Lim, Chae-Jin Daejeon, KR 8 11
Park, Kee-Don Daejeon, KR 3 4
Yoon, Seok-Jeong Daejeon, KR 3 2

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 10, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00